Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

SDi Announces Planned Release of 2018 Global Assessment Report

Posted on: 19 Dec 17

LOS ANGELES, Calif., Dec. 19, 2017 (GLOBE NEWSWIRE) -- Strategic Directions International (SDi), a division of BioInformatics LLC, announced today the 2018 Global Assessment Report: The Laboratory Analytical & Life Science Instrumentation Industry will be released in conjunction with PITTCON, which will take place from February 26 - March 1, 2018. The report is widely considered to be the gold standard of market intelligence for the $50+ billion laboratory market for analytical and life science instruments. The report can be pre-purchased at a significant discount as part of the Company’s 2018 subscription plan.

The report will update projections made in 2017 where market conditions have contributed to growth or contraction. As in the past, detailed information on 82 different product categories is presented in 10 sections that include chromatography, life science instrumentation, mass spectrometry, molecular spectroscopy, atomic spectroscopy, surface science, materials characterization, lab automation, general analytical techniques, and lab equipment.

For this first time, users of the report will have an option to receive an electronic data stream updating the market projections on a quarterly basis.

The announcement was made at the unveiling of the combined SDi/BioInformatics market intelligence portfolio of reports for 2018 that includes 15 titles on both emerging and established markets and the Global Assessment report quarterly data stream. Heavily discounted prices are available for companies that subscribe before year’s end. Corporate subscribers will also receive unlimited access to all market research reports published in the last five years by both SDi and BioInformatics.


Strategic Directions International (SDi), a leading international management-consulting firm in the highly specialized field of analytical instruments, was acquired by BioInformatics LLC in 2014. The two firms combined to form the premier research and advisory firm serving the life science and analytical instrument industry. Our expertise includes assessing the size and attractiveness of markets, optimizing product configurations and pricing, validating corporate acquisitions, measuring customers’ brand loyalty, and evaluating brand strength and positioning, validating corporate acquisitions, measuring customer loyalty, and evaluating brand strength and positioning.

CONTACT: For more information contact: Mike Tice Vice President of Markets & Strategy Strategic Directions International A division of BioInformatics LLC 6242 Westchester Parkway, Suite 100 Los Angeles, CA 90045-4820 United States Phone: 310.641.4982 www.gene2drug.comGlobeNewswire

Last updated on: 20/12/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.